DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Zhu X, Shenhong W, Dahut WL. et al.
Risks of Proteinuria and Hypertension with Bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis.
Am J Kidney Dis 2007; 49: 186-193
Search in:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.